Quantitative and Automated High-throughput Genome-wide RNAi Screens in C. elegans.

Epub ahead of printInternational audienceRNA interference is a powerful method to understand gene function, especially when conducted at a whole-genome scale and in a quantitative context. In C. elegans, gene function can be knocked down simply and efficiently by feeding worms with bacteria expressing a dsRNA corresponding to a specific gene (1). While the creation of libraries of RNAi clones covering most of the C. elegans genome (2,3) opened the way for true functional genomic studies (see for example (4-7)), most established methods are laborious. Moy and colleagues have developed semi-automated protocols that facilitate genome-wide screens (8). The approach relies on microscopic imaging and image analysis. Here we describe an alternative protocol for a high-throughput genome-wide screen, based on robotic handling of bacterial RNAi clones, quantitative analysis using the COPAS Biosort (Union Biometrica (UBI)), and an integrated software: the MBioLIMS (Laboratory Information Management System from Modul-Bio) a technology that provides increased throughput for data management and sample tracking. The method allows screens to be conducted on solid medium plates. This is particularly important for some studies, such as those addressing host-pathogen interactions in C. elegans, since certain microbes do not efficiently infect worms in liquid culture. We show how the method can be used to quantify the importance of genes in anti-fungal innate immunity in C. elegans. In this case, the approach relies on the use of a transgenic strain carrying an epidermal infection-inducible fluorescent reporter gene, with GFP under the control of the promoter of the antimicrobial peptide gene nlp 29 and a red fluorescent reporter that is expressed constitutively in the epidermis. The latter provides an internal control for the functional integrity of the epidermis and nonspecific transgene silencing(9). When control worms are infected by the fungus they fluoresce green. Knocking down by RNAi a gene required for nlp 29 expression results in diminished fluorescence after infection. Currently, this protocol allows more than 3,000 RNAi clones to be tested and analyzed per week, opening the possibility of screening the entire genome in less than 2 months

Criblage par ARN interférence du génome complet de C. elegans pour l' identification de nouveaux gènes impliqués dans l' immunité innée.

Afin de caractériser les voies de signalisation du système immunitaire inné, nous étudions l'interaction entre le ver C. elegans et le champignon Drechmeria coniospora. Une des réponses du ver à l'infection consiste en une augmentation de la production de peptides antimicrobiens (PAM) dans l'épiderme. Des vers transgéniques exprimant le gène rapporteur de la GFP sous le contrôle du promoteur d'un PAM, fluorescent vert après infection. Si un gène nécessaire à l'expression des PAM est inactivé, alors les vers transgéniques ne fluorescent plus après infection. Nous avons effectué un crible pour identifier les molécules de signalisation nécessaires à l'expression des PAM en utilisant une approche quantitative et semi-automatique par ARN interference (ARNi). Deux banques d'ARNi couvrant 95% du génome, soit 20 000 gènes, ont été criblées et 360 candidats bloquant l'induction de la GFP après infection ont été obtenus, correspondant à 343 gènes. Une caractérisation phénotypique a permis de placer les candidats dans différentes catégories fonctionnelles et permis d'identifier d'une part un récepteur agissant en amont de la voie de signalisation p38 nécessaire à l'activation des gènes PAM, d'autre part une implication des granules de stress lors de l'infection. Ces analyses sont le fondement pour l'établissement d'une description compréhensive du réseau génétique régulant le système immunitaire inné du ver et permettront de révéler les interactions complexes entre l'immunité et les processus physiologiques au niveau moléculaire, cellulaire et au niveau de l'organisme.To investigate innate immune signaling, we study the interaction of C. elegans with the fungus Drechmeria coniospora. One of the responses of the worm to this infection is the up-regulation of a variety of antimicrobial peptide (AMP) genes in the epidermis. Transgenic worms carrying a GFP reporter gene under the control of an AMP promoter fluoresce green after infection by D. coniospora. If a gene required for AMP gene expression is inactivated, the reporter strain will not turn green upon infection. Using this fluorescent read-out, we have been able to screen for signaling molecules required for AMP gene expression using a quantitative semi-automated RNAi approach. We have screened two RNAi libraries that together cover 95% of the ca. 20,000 genes in the C. elegans genome and we obtained 360 high-confidence candidates that reduced the level of induction of green fluorescence after infection, and correspond to 343 genes. A further phenotypic characterization allowed the candidates to be grouped into distinct functional categories and allowed the identification of both a receptor acting upstream the p38 MAPK pathway necessary for the activation of the AMPs, and the implication of stress granules during infection. Altogether, the screen data and its analysis represent the foundation for the establishment of a comprehensive description of the signaling network regulating the innate immune system of the worm and will shed light on the complex interactions between immunity and other physiological processes at the molecular, cellular and organismal level

A quantitative genome-wide RNAi screen in C. elegans for antifungal innate immunity genes

International audienceBackground: Caenorhabditis elegans has emerged over the last decade as a useful model for the study of innate immunity. Its infection with the pathogenic fungus Drechmeria coniospora leads to the rapid up-regulation in the epidermis of genes encoding antimicrobial peptides. The molecular basis of antimicrobial peptide gene regulation has been previously characterized through forward genetic screens. Reverse genetics, based on RNAi, provide a complementary approach to dissect the worm's immune defenses. Results: We report here the full results of a quantitative whole-genome RNAi screen in C. elegans for genes involved in regulating antimicrobial peptide gene expression. The results will be a valuable resource for those contemplating similar RNAi-based screens and also reveal the limitations of such an approach. We present several strategies, including a comprehensive class clustering method, to overcome these limitations and which allowed us to characterize the different steps of the interaction between C. elegans and the fungus D. coniospora, leading to a complete description of the MAPK pathway central to innate immunity in C. elegans. The results further revealed a cross-tissue signaling, triggered by mitochondrial dysfunction in the intestine, that suppresses antimicrobial peptide gene expression in the nematode epidermis. Conclusions: Overall, our results provide an unprecedented system's level insight into the regulation of C. elegans innate immunity. They represent a significant contribution to our understanding of host defenses and will lead to a better comprehension of the function and evolution of animal innate immunity

The metaphysical thought of Thomas Aquinas. From the concept of being and unity to the concept of whole and part

The subject-matter of the thesis is the metaphysical thought of the renowned medieval philosopher and theologian Thomas Aquinas (1224/5-1274). The main goal ofthe thesis is to expose Aquinas' part-whole doctrine (mereology) in the broad context of his metaphysical theory. In concrete, we mean to elucidate the part-whole relationship in the background ofthe key metaphysical principles and concepts, such as the notion of being and unity or the issue of the ontological structure of a categorial being. The whole thesis can be divided into two main parts. In the first part we tackle those issues, which must be outlined to comprehend Aquinas' mereology in the broad horizon of his metaphysics. In the second part we set forth the independent attempt to advance Aquinas' part-whole theory

Additional file 8: Table S7. of A quantitative genome-wide RNAi screen in C. elegans for antifungal innate immunity genes

Species used in phylogenetic clustering listed in the same order as in Fig. 8. (XLSX 47 kb

Additional file 1: Table S1. of A quantitative genome-wide RNAi screen in C. elegans for antifungal innate immunity genes

The list of 21,223 clones used in this study. (XLSX 355 kb

Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial

Background: Soft-tissue sarcomas (STS) represent a heterogeneous group of rare tumors including more than 70 different histological subtypes. High throughput molecular analysis (next generation sequencing exome [NGS]) is a unique opportunity to identify driver mutations that can change the usual one-size-fits-all treatment paradigm to a patient-driven therapeutic strategy. The primary objective of the MULTISARC trial is to assess whether NGS can be conducted for a large proportion of metastatic STS participants within a reasonable time, and, secondarily to determine whether a NGS-guided therapeutic strategy improves participant's outcome. Methods: This is a randomized, multicentre, phase II/III trial inspired by the design of umbrella and biomarker-driven trials. The setting plans up to 17 investigational centres across France and the recruitment of 960 participants. Participants aged at least 18 years, with unresectable locally advanced and/or metastatic STS confirmed by the French sarcoma pathological reference network, are randomized according to 1:1 allocation ratio between the experimental arm "NGS" and the standard "No NGS". NGS will be considered feasible if (i) NGS results are available and interpretable, and (ii) a report of exome sequencing including a clinical recommendation from a multidisciplinary tumor board is provided to investigators within 7 weeks from reception of the samples on the biopathological platform. A feasibility rate of more than 70% is expected (null hypothesis: 70% versus alternative hypothesis: 80%). In terms of care, participants randomized in "No NGS" arm and who fail treatment will be able to switch to the NGS arm at the request of the investigator. Discussion: The MULTISARC trial is a prospective study designed to provide high-level evidence to support the implementation of NGS in routine clinical practice for advanced STS participants, on a large scale. Trial registration: clinicaltrial.gov NCT03784014